Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06269367 · ClinicalTrials.gov registry record · NA

NewGait: A Low-Cost Rehabilitation System to Improve Post-Stroke Gait (Biomechanical Adaptations)

A NA study of Stroke, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06269367 is a NA study of Stroke that has completed, run by University of Michigan. The registered enrollment target is 20 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06269367, a NA study of Stroke, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

An affordable and easy to use gait-assistive device for stroke survivors to use at home is yet to be developed. This study is intended to modify the current design of the NewGait device to specifically work for stroke survivors based on feedback from patients and clinicians. Consequently, conducting a short-term biomechanical gait study is planned to determine the usability and functionality of the NewGait device compared to other comparative devices.

Conditions Studied

Interventions

  • OTHER NewGait
  • OTHER Control wearable limb orthotic device

Study Locations (1)

Michigan

  • Physical Medicine & Rehabilitation 325 E Eisenhower Pkwy Suite 3011 - Ann Arbor

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-04-01
Est. Completion 2024-12-09
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT06269367

The ClinicalTrials.gov registry entry for NCT06269367 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which NewGait is the first listed.

NCT06269367 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT06269367 about?

NCT06269367 is a clinical study titled "NewGait: A Low-Cost Rehabilitation System to Improve Post-Stroke Gait (Biomechanical Adaptations)". An affordable and easy to use gait-assistive device for stroke survivors to use at home is yet to be developed. This study is intended to modify the current design of the NewGait device to specifically work for stroke survivors based on feedback from patients and clinicians. Consequently, conducting...

What is the current status of trial NCT06269367?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2024-04-01. Estimated completion is 2024-12-09.

What conditions does trial NCT06269367 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT06269367?

The interventions under investigation include: NewGait (OTHER), Control wearable limb orthotic device (OTHER).

Who is sponsoring clinical trial NCT06269367?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06269367 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.